Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study

Background: We report long-term safety and immunogenicity of Takeda's tetravalent dengue vaccine candidate (TAK-003) in healthy children and adults living in dengue-endemic areas in Puerto Rico, Columbia, Singapore, and Thailand. Methods: In part 1 of this phase 2, randomized, placebo-controlle...

Full description

Saved in:
Bibliographic Details
Main Author: Sirivichayakul C.
Other Authors: Mahidol University
Format: Article
Published: 2023
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/85950
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University